Avricore Health (TSE:AVCR) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Avricore Health Inc. reports a striking leap in financial performance for 2023, nearly doubling its revenues to over $3.4 million and expanding its gross profit by 163%. The company has also broadened its HealthTab™ network, partnering with Ascensia Diabetes Care to enhance diabetes management in pharmacies across Canada. Additionally, Avricore has vastly increased its presence in Shoppers Drug Mart locations nationwide, further establishing its foothold in the healthcare sector.
For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.